PT93137A - Processo para a preparacao de n-fenil-n-(4-piperidinil) amidas - Google Patents

Processo para a preparacao de n-fenil-n-(4-piperidinil) amidas

Info

Publication number
PT93137A
PT93137A PT93137A PT9313790A PT93137A PT 93137 A PT93137 A PT 93137A PT 93137 A PT93137 A PT 93137A PT 9313790 A PT9313790 A PT 9313790A PT 93137 A PT93137 A PT 93137A
Authority
PT
Portugal
Prior art keywords
lower alkyl
group
alkoxy
member selected
carbonyl
Prior art date
Application number
PT93137A
Other languages
English (en)
Other versions
PT93137B (pt
Inventor
Paul L Feldman
Michael K James
Marcus F Brackeen
Michael Ross Johnson
Harry Jefferson Leighton
Original Assignee
Glaxo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Inc filed Critical Glaxo Inc
Publication of PT93137A publication Critical patent/PT93137A/pt
Publication of PT93137B publication Critical patent/PT93137B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT93137A 1989-02-15 1990-02-14 Processo para a preparacao de n-fenil-n-(4-piperidinil) amidas PT93137B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31131189A 1989-02-15 1989-02-15
US07/448,497 US5019583A (en) 1989-02-15 1989-12-11 N-phenyl-N-(4-piperidinyl)amides useful as analgesics

Publications (2)

Publication Number Publication Date
PT93137A true PT93137A (pt) 1990-08-31
PT93137B PT93137B (pt) 1996-02-29

Family

ID=26977841

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93137A PT93137B (pt) 1989-02-15 1990-02-14 Processo para a preparacao de n-fenil-n-(4-piperidinil) amidas

Country Status (22)

Country Link
US (1) US5019583A (pt)
EP (1) EP0383579B1 (pt)
JP (1) JP2895145B2 (pt)
KR (1) KR0160979B1 (pt)
AT (1) ATE140451T1 (pt)
AU (1) AU636330B2 (pt)
CA (1) CA2010011C (pt)
CY (1) CY2002A (pt)
CZ (1) CZ402591A3 (pt)
DE (2) DE19675028I2 (pt)
DK (1) DK0383579T3 (pt)
ES (1) ES2088961T4 (pt)
GR (1) GR3020719T3 (pt)
HK (1) HK78297A (pt)
IE (1) IE77156B1 (pt)
LU (1) LU90011I2 (pt)
MX (1) MX9203024A (pt)
NL (1) NL960030I2 (pt)
NZ (1) NZ232542A (pt)
PT (1) PT93137B (pt)
SG (1) SG47967A1 (pt)
SK (1) SK402591A3 (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130321A (en) * 1990-12-18 1992-07-14 Glaxo Inc. Analgesic n-phenyl-n-(3-or 1-3-me-4-piperidinyl)amides
US5214148A (en) * 1990-12-18 1993-05-25 Glaxo Inc. Analgesic N-phenyl-N-(3-OR1 -3-ME-4-piperidinyl)amides
GB9316863D0 (en) * 1993-08-13 1993-09-29 Glaxo Group Ltd Chemical process
US5466700A (en) * 1993-08-30 1995-11-14 Glaxo Wellcome Inc. Anesthetic use of N-phenyl-N-(4-piperidinyl)amides
US5866591A (en) * 1996-09-11 1999-02-02 Glaxo Wellcome Inc. Stable formulations of remifentanil
CA2316341A1 (en) * 1997-12-24 1999-07-08 Ortho-Mcneil Pharmaceutical, Inc. 4-[aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
US6858018B1 (en) * 1998-09-28 2005-02-22 Vyteris, Inc. Iontophoretic devices
US6436959B1 (en) 1998-12-23 2002-08-20 Ortho-Mcneil Pharmaceutical, Inc. 4-[aryl(piperidin-4-yl)]aminobenzamides
ES2272354T3 (es) 1999-12-06 2007-05-01 Mallinckrodt Inc. Metodos para la sintesis de alfentanilo,sufentanilo remifentanilo.
AU2001238690A1 (en) 2000-03-14 2001-09-24 Sepracor, Inc. 3-substituted piperidines comprising urea functionality, and methods of use thereof
DE60133203T3 (de) * 2000-07-31 2012-02-23 Nycomed Danmark Aps Fentanyl Zusammensetzung für nasale Anwendung
EP1414798A2 (en) 2001-04-03 2004-05-06 Aryx Therapeutics Ultrashort-acting opioids for transdermal application
JP2005516926A (ja) * 2001-12-17 2005-06-09 アリックス セラピューティクス 鎮痛薬の送達システム及び使用方法
WO2005030722A1 (ja) * 2003-09-29 2005-04-07 Nippon Chemiphar Co., Ltd. N-置換-n-(4-ピペリジニル)アミド誘導体
CA2570075A1 (en) 2004-06-18 2005-12-29 Neurosearch A/S Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2006030931A1 (ja) * 2004-09-14 2006-03-23 Nippon Chemiphar Co., Ltd. N-置換-n-(4-ピペリジニル)アミド誘導体
WO2007061555A1 (en) * 2005-11-17 2007-05-31 Mallinckrodt Inc. Process for synthesizing remifentanil
US20080312448A1 (en) * 2006-01-24 2008-12-18 Cheng Brian K Process for Synthesizing Remifentanil
CA2641283A1 (en) * 2006-02-03 2007-08-16 Mallinckrodt Inc. Crystalline form of remifentanil hydrochloride
EP1867635A1 (en) * 2006-06-15 2007-12-19 Kern Pharma, S.L. Process for preparing remifentanil, intermediates thereof, use of said intermediates and processes for their preparation
BRPI0714886B8 (pt) 2006-07-10 2021-05-25 Paion Uk Ltd sais de benzodiazepina, seus usos e seus processos de preparação, e composição farmacêutica
GB0613693D0 (en) * 2006-07-10 2006-08-16 Cenes Ltd Benzodiazepine salts (3)
US20100099880A1 (en) * 2006-10-05 2010-04-22 Brian Cheng Alternate Process for Remifentanil Preparation
WO2008066708A2 (en) * 2006-11-29 2008-06-05 Mallinckrodt Inc. New process for remifentanil synthesis
RU2540116C2 (ru) 2008-03-31 2015-02-10 Дзе Дженерал Хоспитал Корпорейшн Аналоги этомидата с улучшенными фармакокинетическими и фармакодинамическими свойствами
EP2310365A1 (de) * 2008-07-03 2011-04-20 Cilag AG Verfahren zur herstellung von n-phenyl-n-(4-piperidinyl) amidsalzen
US8299258B2 (en) * 2008-11-04 2012-10-30 Cambrex Charles City Method of making piperidine derivatives
WO2011005969A2 (en) 2009-07-10 2011-01-13 The General Hospital Corporation Etomidate analogues that do not inhibit adrenocortical steroid synthesis
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
CN104168899B (zh) 2012-01-13 2017-04-05 通用医疗公司 麻醉剂化合物及其相关的使用方法
AU2013328280B2 (en) 2012-10-08 2017-12-21 Auckland Uniservices Limited Ketamine derivatives
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión
CN103728403B (zh) * 2013-08-30 2015-10-07 宜昌人福药业有限责任公司 一种盐酸瑞芬太尼原料药中有关物质的检测方法
PT3199523T (pt) 2016-01-29 2018-11-14 Bioka S R O Novo procedimento de fabricação do n-fenil-n-(4-piperidinil) dos derivados de amida, como é a remifentanila e a carfentanila
PT3643704T (pt) 2018-10-26 2021-03-08 Hameln Pharma Gmbh Novos intermediários para a preparação de hidrocloreto de remifentanil
GB202010168D0 (en) * 2020-07-02 2020-08-19 Johnson Matthey Plc Process for preparing remifentanil hydrochloride
CN114262320A (zh) * 2021-12-28 2022-04-01 宜昌人福药业有限责任公司 一种利用连续流微通道反应器制备苯胺基哌啶类药物的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL284196A (pt) * 1961-10-10
US3655675A (en) * 1968-09-09 1972-04-11 Sterling Drug Inc N-(n-heteryl)-acylanilides
US4179569A (en) * 1975-03-14 1979-12-18 Janssen Pharmaceutica N.V. N-(4-piperidinyl)-N-phenylamides
US3998834A (en) * 1975-03-14 1976-12-21 Janssen Pharmaceutica N.V. N-(4-piperidinyl)-n-phenylamides and -carbamates
US4167574A (en) * 1978-03-13 1979-09-11 Janssen Pharmaceutica, N.V. N-phenyl-N-(4-piperidinyl)amides
US4584303A (en) * 1984-04-09 1986-04-22 The Boc Group, Inc. N-aryl-N-(4-piperidinyl)amides and pharmaceutical compositions and method employing such compounds
US4801721A (en) * 1984-08-16 1989-01-31 Ryan James W Stereospecific synthesis of carboxyalkyl peptides
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides

Also Published As

Publication number Publication date
IE900532L (en) 1990-08-15
KR0160979B1 (ko) 1998-12-01
HK78297A (en) 1997-06-20
DE69027794D1 (de) 1996-08-22
NZ232542A (en) 1992-06-25
ES2088961T4 (es) 1996-12-01
SK402591A3 (en) 2000-09-12
AU636330B2 (en) 1993-04-29
CZ402591A3 (en) 1993-04-14
PT93137B (pt) 1996-02-29
EP0383579A1 (en) 1990-08-22
US5019583A (en) 1991-05-28
SG47967A1 (en) 1998-04-17
IE77156B1 (en) 1997-12-03
LU90011I2 (fr) 1997-03-11
DE69027794T2 (de) 1997-01-02
ATE140451T1 (de) 1996-08-15
JP2895145B2 (ja) 1999-05-24
CY2002A (en) 1997-12-05
NL960030I1 (nl) 1997-02-03
GR3020719T3 (en) 1996-11-30
MX9203024A (es) 1992-07-01
CA2010011C (en) 1997-12-02
DE19675028I2 (de) 2002-11-07
JPH02300167A (ja) 1990-12-12
KR900012906A (ko) 1990-09-03
NL960030I2 (nl) 1997-05-01
AU4973190A (en) 1990-08-23
EP0383579B1 (en) 1996-07-17
DK0383579T3 (da) 1996-10-14
ES2088961T3 (es) 1996-10-01
CA2010011A1 (en) 1990-08-15

Similar Documents

Publication Publication Date Title
AU636330B2 (en) N-phenyl-n-(4-piperidinyl)amides useful as analgesics
BR9912494B1 (pt) derivado de di ou trifluorometanossulfonil anilida, processo para a sua produção e herbicida contendo o referido derivado como ingrediente ativo.
ATE33835T1 (de) Verbindung mit antibronchopneumopathischer wirkung, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
MX11031A (es) Proceso para la preparacion de nuevas 1-fenil-3-naftaleniloxipropanaminas producto obtenido y composicion farmaceutica que lo incluye.
PT94297A (pt) Processo para a preparacao de n-hetero-aril-purin-6-aminas e de composicoes farmaceuticas que as contem
PT90725A (pt) Processo para a preparacao de novos compostos cefem
DK26289D0 (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
HUT57773A (en) Process for produicng n-(aminocarbonyl)-carbamates related to physostigmine, as well as pharmaceutical compositions comprising such compounds
DZ1560A1 (fr) Procédé de préparation, d'un dérivé de benzothiazole, et d'une compostion pharmaceutique le contenant et procédé de traitement en comportant application.
EP0246507A1 (en) N-cyanoalkylisonicotinamide derivatives
HUT50352A (en) Process for producing new antiviral prine derivatives and pharmaceutical compositions comprising same
BR9813607A (pt) Composto, processo para preparar o mesmo, composição farmacêutica, e, processo para tratar uma condição de doença
DK0494604T3 (da) 1-Piperazinyl-2-butener og -2-butyner, mellemprodukter derfor, en fremgangsmåde til fremstilling deraf og deres anvendelse
DK0427518T3 (da) NMDA-blokerende forbindelser, farmaceutiske præparater, deres fremstilling og anvendelse
PT94036A (pt) Processo para a preparacao de piridazinaminas anti-rinovirais
IL99434A0 (en) 3-(1h-indazol-3-yl)-4-pyridinamines,a process and intermediates for their preparation and pharmaceutical compositions containing them
PT911336E (pt) Derivados do acido piridonacarboxilico e intermediarios para a sua sintese
PT96017A (pt) Processo para a preparacao de hexahidro-1h-quino{4,3,2-ef}{1,4}benzoxazeinas e de composicoes farmaceuticas que os contem
DK259388D0 (da) 1-(n-(2-alkylthio-10h-phenothiazin-10-yl)alkyl)-4-benzoylpiperidiner, deres fremstilling og anvendelse
MY136018A (en) Di - or trifluoromethanesulfonyl anilide derivative, process for production thereof, and herbicide containing said derivative as active ingredient

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19951114

PC4A Transfer of assignment

Owner name: GLAXO WELLCOME INC., US

Effective date: 20090624

Owner name: SMITHKLINE BEECHAM CORPORATION, US

Effective date: 20090624

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20101115